van de Pavert, S. H. P., Muhlert, Nils ORCID: https://orcid.org/0000-0002-6414-5589, Sethi, V., Wheeler-Kingshott, C. A. M., Ridgway, G. R., Geurts, J. J. G., Ron, M., Yousry, T. A., Thompson, A. J., Miller, D. H., Chard, D. T. and Ciccarelli, O. 2016. DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime? Journal of Neurology, Neurosurgery & Psychiatry 87 (5) , pp. 461-467. 10.1136/jnnp-2014-310142 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (647kB) | Preview |
Abstract
Background The extent and clinical relevance of grey matter (GM) pathology in multiple sclerosis (MS) are increasingly recognised. GM pathology may present as focal lesions, which can be visualised using double inversion recovery (DIR) MRI, or as diffuse pathology, which can manifest as atrophy. It is, however, unclear whether the diffuse atrophy centres on focal lesions. This study aimed to determine if GM lesions and GM atrophy colocalise, and to assess their independent relationship with motor and cognitive deficits in MS. Methods Eighty people with MS and 30 healthy controls underwent brain volumetric T1-weighted and DIR MRI at 3 T, and had a comprehensive neurological and cognitive assessment. Probability mapping of GM lesions marked on the DIR scans and voxel- based morphometry (assessing GM atrophy) were carried out. The associations of GM lesion load and GM volume with clinical scores were tested. Results DIR-visible GM lesions were most commonly found in the right cerebellum and most apparent in patients with primary progressive MS. Deep GM structures appeared largely free from lesions, but showed considerable atrophy, particularly in the thalamus, caudate, pallidum and putamen, and this was most apparent in secondary progressive patients with MS. Very little co-localisation of GM atrophy and lesions was seen, and this was generally confined to the cerebellum and postcentral gyrus. In both regions, GM lesions and volume independently correlated with physical disability and cognitive performance. Conclusions DIR-detectable GM lesions and GM atrophy do not significantly overlap in the brain but, when they do, they independently contribute to clinical disability.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Psychology |
Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
Publisher: | BMJ Publishing Group |
ISSN: | 0022-3050 |
Date of First Compliant Deposit: | 30 March 2016 |
Date of Acceptance: | 10 April 2015 |
Last Modified: | 05 May 2023 16:22 |
URI: | https://orca.cardiff.ac.uk/id/eprint/72967 |
Citation Data
Cited 32 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |